Alzheimer's drug adoption in US slowed by doctors' skepticism

Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among ... Read More

National and World news stories | Newsday

Read the latest national and world news, including stories from Newsday's reporters in Washington, D.C. Young brother and sister dead, several hurt when vehicle crashes into Michigan birthday ... Read More

FDA faces backlash over approval of genetic test for opioid addiction risk

The Food and Drug Administration is facing backlash over its approval of a ... voted against AvertD’s approval on the FDA’s advisory panel in 2022. He said that even the agency has ... Read More

World News

The U.S. Senate approved a package that includes $26 billion in aid for Israel and for civilians in conflict zones, including Gaza, over objections ... a team in the world’s richest sports ... Read More

The FDA Approved The World's Most Expensive Drug Last Week, A $4.25 Million One-Time Gene Treatment For An Ultra-Rare Nerve Disorder Typically Found In Toddlers

The FDA Approved The World's Most Expensive Drug Last Week, A $4.25 Million One-Time Gene Treatment For An Ultra-Rare Nerve Disorder Typically Found In Toddlers Story by Emily Chan • 4w • 2 ... Read More

Column: FDA shoots itself in the foot by settling a groundless lawsuit over its ivermectin warnings

“You are not a horse,” read a tweet posted by the Food and Drug Administration on Aug. 21 ... the tweet than a zoological judgment. The FDA’s goal was to advise individuals against taking ... Read More

Alzheimer's News

In the study, almost one in ten of over 50-year-olds ... role in the development of Alzheimer's disease and heart conditions can be lessened by three kinds of drug inhibitors, according to ... Read More

FDA approves new drug that may help stop a rare, fatal condition that doctors call a ‘ticking time bomb’

These proteins cause the walls of a person’s blood vessels to keep growing and thicken over time ... Instead, Galiatsatos said, the FDA approved the drug based on other signs of effectiveness ... Read More

FDA faces backlash over approval of genetic test for opioid addiction risk

The Food and Drug ... over its approval of a genetic test intended to determine if a person is at increased risk for opioid addiction. The test, called AvertD, was approved by the FDA in December. Read More

FDA faces backlash over approval of genetic test for opioid addiction risk

The FDA is facing backlash for approving a genetic test that is supposed to show if you are at risk for an opioid addiction. A group of scientists and researchers say that this test does not ... Read More